Xanax, marked with imprint R 0 3 9, is a medication supplied by Actavis. These tablets are rectangular and yellow in color, containing 2 mg of Alprazolam, classified as a benzodiazepine. Alprazolam is primarily prescribed to alleviate symptoms associated with anxiety disorders, panic attacks, and other related conditions affecting the central nervous system.
Uses: Alprazolam works within the brain and nerves (central nervous system) by enhancing the effects of natural chemicals that produce a calming effect. It is effective in managing:
- Anxiety disorders
- Panic disorders
Precautions: Before taking Alprazolam, inform your healthcare provider about any allergies to Alprazolam or other benzodiazepines (e.g., Diazepam, Lorazepam) and any other allergies you may have. This medication may contain inactive ingredients that can cause allergic reactions or other problems.
Prior to using this medication, disclose your medical history, especially if you have a history of severe respiratory problems (e.g., COPD, sleep apnea), liver disease, kidney disease, or a personal/family history of substance use disorders (e.g., overuse or addiction to drugs/alcohol), or glaucoma.
Overdose: In case of overdose with severe symptoms such as fainting or difficulty breathing, seek emergency medical assistance immediately. Contact poison control at 1-800-222-1222 (USA) or your local provincial Poison Control Center (Canada). Symptoms of overdose may include severe drowsiness, slowed reflexes, shallow breathing, and loss of consciousness.
Notes:
- Do not share this medication with others; it is illegal and against the law.
- Regular medical examinations and laboratory tests (e.g., liver function tests) should be conducted to monitor progress and detect any potential side effects. Consult your doctor for more information.
This detailed description provides comprehensive information about Xanax (Alprazolam) 2 mg tablets, helping users understand its uses, precautions, and potential risks associated with its use.
Reviews
There are no reviews yet.